Blood Biomarker Shows Promise Predicting Progression to Alzheimer’s
Researchers confirmed the usefulness of NfL blood levels to predict the likelihood of progression of neurodegeneration in Alzheimer’s.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Most Older Adults Haven’t Tested for Alzheimer’s Despite Benefits
Approximately 80% of older adults haven’t had a cognitive test in the past year to look for signs of Alzheimer’s or other types of dementia.
Dementias & Alzheimer’s
Latest
Is Early Diagnosis the Key to Making Alzheimer’s Disease a Manageable Condition?
It is estimated that one in 10 elderly Americans have Alzheimer’s Disease. A new test may aid in making it a manageable condition.
Biomarker Identified for Vascular Dementia Diagnosis
Measuring a key blood molecule may help diagnose whether or how much impaired blood flow to a patient’s brain is contributing to dementia.
Read More
New SYNAPS Dx Skin Test More Accurately Diagnoses Alzheimer’s
A new study indicates that 90% of physicians would use the results of the DISCERN test to more accurately diagnose Alzheimer’s.
Read More
Focused Ultrasound Helps Release Neurodegenerative Disorder Biomarkers
A noninvasive, focused-ultrasound-mediated liquid biopsy could help facilitate diagnosis of neurodegenerative disorders.
Read More
New Test Could Detect Alzheimer’s Years Before Clinical Diagnosis
Researchers established a blood test that may predict the risk of Alzheimer’s disease up to three and half years before clinical diagnosis.
Read More
SYNAPS Dx Demonstrates Physician Burden in Diagnosing Alzheimer’s Disease
New data suggests that over half of symptomatic Alzheimer’s patients are misdiagnosed for the disease in the primary care setting.
Read More
SFU Scientists Developing Early Alzheimer’s Detection Sensor
Researchers are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases early.
Read More
New Smart Intraocular Lens Tech Diagnoses Early-Stage Alzheimer’s
A smart intraocular lens that can be inserted into the eye to diagnose Alzheimer’s has been developed in Korea.
Read More
Patent Issued for Early Detectable Blood-Based Biomarker for Alzheimer’s
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read More
Blood Markers May Reveal Alzheimer’s a Decade Before Symptoms Show
A new study on an inherited form of Alzheimer’s shows that the GFAP protein is a possible biomarker for very early stages of the disease.
Read More
AlzoSure Prognostic Blood Test for Alzheimer’s Disease Will Help Patients
Diadem SpA presented clinical data highlighting the accuracy and utility of its AlzoSure Predict prognostic blood test for Alzheimer’s.
Read More
Blood Biomarker Test Can Spot Alzheimer’s Neurodegeneration
Researchers have developed a blood biomarker test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample.
Read More
Scientists Identify Predictive Blood Biomarker for Cognitive Impairment, Dementia
A recent study revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia.
Read More
Piwi-interacting RNA Discovery Lays Groundwork for New Diagnostic Technologies
Researchers have discovered a correlation between Piwi-interacting RNA and brain inflammation, which will lead to new diagnostic techniques.
Read More
Start-Up Gets Federal Support to Develop Early Alzheimer’s Diagnosis Tech
A start-up company received federal support to develop a new technology that can be used for early diagnosis of Alzheimer’s disease.
Read More
Roche Alzheimer’s Disease Cerebrospinal Fluid Assays Receive FDA Clearance
Roche’s Elecsys beta-Amyloid CSF II and Elecsys Phospho-Tau CSF assays received U.S. FDA 510(k) clearance to evaluate Alzheimer’s
Read More